PTC Therapeutics Inc (NASDAQ: PTCT) stock closed at $52.07 on 12/2/24 after a major increase of 18.7%. Moreover, exceptionally high trading volume at 415% of normal accompanied the advance. The stock has been exceptionally strong relative to the market over the last nine months and has risen 21.4% during the last week.
Current PriceTarget Research Rating
PTC Therapeutics is currently unrated.
Rating Review
The stock is currently unrated.
Be the first to comment